StocksRunner logo
 
 
 
 
»
 

Should You Consider Adding Sugar ETF (CANE) to Your Investment Portfolio?

 
 
 
 

Sugar, Yes Sugar is in a positive momentum in the last month?
So should you buy some sugar? You can buy the Teucrium Sugar ETF -CANE. The fund just hit a 52-week high, and is up 22.9% from its 52-week low of $8.56 per share.

 

There are many factors that can affect sugar prices, however there 2 main factors among them:

 

1. Weather

 

Sugar is typically grown in tropical regions and is sensitive to changes in weather patterns, such as droughts or floods. If weather conditions are unfavorable, sugar production may decrease, leading to lower supply and higher prices.

 

2. Demand

 

Changes in consumer preferences and dietary trends can affect the demand for sugar. For example, if there is a shift towards low-sugar or sugar-free products, demand for sugar may decrease, leading to lower prices.

 

So why the sugar price is soaring?

 

Mexico is a critical factor.

 

After suffering from lower yields due to inclement weather throughout its production cycle, the current cane crop in Mexico will be unable to meet the US target quantity of 1.3 million tonnes as it only has about 1 million tonnes available for export.

 

Estimates for Mexico’s sugar production in 2022-23 ranged from 5.5 million tonnes to about 5.8 million tonnes, compared with 5.9 million tonnes as the current US Department of Agriculture forecast.
Mexico’s production levels would need to be closer to 6 million tonnes to satisfy domestic needs in Mexico and the export limit demand from the United States.

 

The consensus from market analysts speaking at the International Sweetener Colloquium is that domestic sugar prices for the 2023-24 marketing year are up, and they’re likely going to stay up or move higher.In addition, Robust demand amid stubborn inflation was a key supportive element, but analysts spotlighted supply issues as a major driving force behind recent price hikes.

 

Humberto Jasso, executive president of the Mexican Sugar Chamber, acknowledged the country’s sugar production struggles but countered that shipments of sugar to the United States from Mexico have not been affected. Mr. Jasso said there was difficulty in forecasting overall production levels for 2022-23 due to atypical rains in November and December that affected sugar yield, but he asserted this would likely be offset by the historically high level of acres planted to sugar cane.

 

But are more gains in store for this sugar ETF?

 

Raw sugar futures in the United States are hovering around the six-year peak due to tight supply from the world’s top producers. India revised sugar production expectations lower to 34.3 million tonnes in the current marketing year, as lower solar radiation weighed on crops and resulted in early maturation of the incoming cane harvest. So are More Gains Ahead?

 

if the supply stays strong. The answer is probably positive. Keep sugar on your radar.

 
 
unlock
 
 
 

Please note that the article should not be considered as investment advice or marketing, and it does not take into account the personal data and requirements of any individual. It is not a substitute for the reader's own judgment, and it should not be considered as advice or recommendation for buying or selling any securities or financial products.

 

Comments

 

Please Login to add comment

 
 
 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our Daily Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner

StocksRunner

Get the pulse of the market

 
 
 
StocksRunner

Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our Daily Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.